Five
oxazole-containing
macrolides isolated from the marine sponge Chondrosia corticata were evaluated for their anti-proliferative activity in a panel of human solid
cancer cell lines.
(19Z)-Halichondramide ((19Z)-HCA), a novel trisoxazole-containing
macrolide, exhibited the highest potency among the
macrolides, with IC50 values in the submicro-molar ranges. Prompted by the high potency of growth inhibition of
cancer cells, we investigated the mechanism of action of the anti-proliferative activity of (19Z)-HCA in human A549
lung cancer cells. (19Z)-HCA induced cell cycle arrest in the G2/M phase, and this event was highly correlated with the expression of checkpoint
proteins, including the up-regulation of p53 and GADD45α and the down-regulation of
cyclin B1,
cyclin A, CDC2, and CDC25C. In addition, the growth inhibition by (19Z)-HCA was associated with the suppression of mTOR and its downstream effector molecules 4EBP1 and
p70S6K. The modulation of mTOR signaling by (19Z)-HCA was found to be mediated by the regulation of upstream
proteins, including the down-regulation of Akt and
p38 MAPK and the up-regulation of AMPK. These data suggest the potential of (19Z)-HCA to serve as a candidate for
cancer chemotherapeutic agents derived from marine organisms by virtue of arresting the cell cycle in the G2/M phase and the modulation of mTOR/AMPK signaling pathways.